MIFEGEN Trademark

Trademark Overview

On Thursday, April 5, 2018, a trademark application was filed for MIFEGEN with the United States Patent and Trademark Office. The USPTO has given the MIFEGEN trademark a serial number of 87865234. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 6, 2021. This trademark is owned by Danco Laboratories, LLC. The MIFEGEN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the interruption of pregnancy
mifegen

General Information

Serial Number87865234
Word MarkMIFEGEN
Filing DateThursday, April 5, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 6, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 4, 2018

Trademark Statements

Goods and ServicesPharmaceuticals for the interruption of pregnancy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 13, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDanco Laboratories, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNashville, TN 37215
Party NameDanco Laboratories, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNashville, TN 37215

Trademark Events

Event DateEvent Description
Monday, December 6, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 6, 2021ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 19, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 19, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 19, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, August 19, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 19, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 19, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 6, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 5, 2021EXTENSION 5 GRANTED
Friday, March 19, 2021EXTENSION 5 FILED
Monday, April 5, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 19, 2021TEAS EXTENSION RECEIVED
Thursday, October 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 6, 2020EXTENSION 4 GRANTED
Tuesday, October 6, 2020EXTENSION 4 FILED
Tuesday, October 6, 2020TEAS EXTENSION RECEIVED
Thursday, April 9, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 7, 2020EXTENSION 3 GRANTED
Tuesday, April 7, 2020EXTENSION 3 FILED
Tuesday, April 7, 2020TEAS EXTENSION RECEIVED
Thursday, September 26, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 24, 2019EXTENSION 2 GRANTED
Tuesday, September 24, 2019EXTENSION 2 FILED
Tuesday, September 24, 2019TEAS EXTENSION RECEIVED
Saturday, March 30, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 28, 2019EXTENSION 1 GRANTED
Thursday, March 28, 2019EXTENSION 1 FILED
Thursday, March 28, 2019TEAS EXTENSION RECEIVED
Tuesday, October 30, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 4, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 4, 2018PUBLISHED FOR OPPOSITION
Wednesday, August 15, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 24, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 24, 2018ASSIGNED TO EXAMINER
Friday, April 13, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 9, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

mifegen pregnancy interruption pharmaceuticals